Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in non-small cell lung carcinoma patients responding to atezolizumab treatment. (March 2019) - Fehlings, M.; Nardin, A.; Jhunjhunwala, S.; Kowanetz, M.; O'Gorman, B.; Hegde, P.; Li, J.; Sumatoh, H.; Lee, B.; Kim, L.; Flynn, S.; Ballinger, M.; et al.